A landmark international study uncovers shared biological pathways that could reshape mental health treatment
Scientists have long known that disorders such as schizophrenia, depression, bipolar disorder, autism, ADHD, and insomnia often run in families. Yet researchers have struggled to explain exactly why these conditions sometimes overlap and what biological mechanisms drive them.
Now, an international team of researchers has uncovered evidence that three genes may serve as central biological links between six major psychiatric and neurodevelopmental disorders. Their findings suggest that seemingly different mental illnesses may share common molecular pathways, opening the door to new diagnostic tools and treatments that target the underlying biology rather than simply managing symptoms.
An international collaboration searches for common causes
The research was conducted by scientists from Fudan University, King’s College London, University Paris-Saclay, and several other institutions. Published in Nature Mental Health, the study represents one of the largest analyses to examine the relationship between genetics, immune function, and psychiatric disease.
Instead of studying people already diagnosed with mental illness, the researchers analyzed blood-derived biological data from 1,274 healthy adolescents participating in the European IMAGEN Project. Their goal was to identify biological changes that occur before psychiatric disorders develop.
As the researchers wrote, “The biological mechanisms underlying major neuropsychiatric disorders remain largely elusive.” They hoped to identify “transdiagnostic biomarkers and mechanisms that could inform diagnosis and treatment.”
Six disorders connected by shared biology
The study focused on six conditions:
- Attention-deficit/hyperactivity disorder (ADHD)
- Autism spectrum disorder (ASD)
- Bipolar disorder
- Major depressive disorder
- Schizophrenia
- Insomnia
Although each disorder has distinct symptoms, many patients experience more than one during their lifetime. This has led scientists to suspect they may share underlying biological processes.
The new research provides strong evidence that this may be true.
Three genes stand out
Among dozens of genes identified during the study, three emerged as especially important:
- MAD1L1
- MRPL2
- HLA-DRB1
MRPL2 was linked to both schizophrenia and insomnia. The researchers found that DNA methylation reduced expression of this gene, increasing the risk of both disorders. Because MRPL2 helps regulate mitochondrial function, the findings strengthen growing evidence that disruptions in cellular energy production may contribute to psychiatric disease.
MAD1L1 also appeared to play a major role. Increased expression of the gene was linked to schizophrenia, reinforcing previous genetic studies that had identified it as an important risk factor.
HLA-DRB1, meanwhile, is heavily involved in immune system regulation. Increased activity of this gene was also associated with schizophrenia, adding to growing evidence that immune dysfunction may contribute to certain psychiatric disorders.
How the scientists made the discovery
The researchers used a sophisticated multi-omics approach that examined several layers of biology simultaneously, including genetic variants, DNA methylation, gene expression, and immune system activity.
DNA methylation acts like a biological dimmer switch. Small chemical tags attach to DNA and influence whether genes become more or less active without changing the genetic code itself.
The team then used advanced statistical methods known as Mendelian randomization and colocalization analyses to determine whether these molecular changes were likely causing disease rather than simply occurring alongside it. This allowed the researchers to identify biological pathways that appear to play a direct role in psychiatric illness.
The immune system may play an important role
One of the study’s most surprising findings involved the immune system.
Many of the identified genes were also associated with autoimmune diseases such as asthma, ulcerative colitis, and type 1 diabetes. The researchers concluded that psychiatric disorders and autoimmune diseases may share parts of the same genetic architecture.
“The identified genes were significantly enriched in pathways linked to both psychiatric and autoimmune diseases,” the authors wrote.
This growing connection suggests that inflammation and abnormal immune signaling may influence brain development and mental health more than previously believed.
What this means for future treatment
Today’s psychiatric medications primarily manage symptoms rather than addressing the underlying biology of mental illness.
By identifying shared molecular pathways, scientists may eventually develop therapies that target the biological processes driving multiple disorders at once. The discoveries could also lead to blood tests capable of identifying people at elevated risk years before symptoms appear, allowing earlier intervention during adolescence.
The researchers concluded that their findings highlight “key molecular mechanisms and genes implicated in neuropsychiatric disorders, offering promising new targets for therapeutic intervention.”
A new direction for psychiatry
Researchers caution that no single gene causes mental illness. Environmental influences, life experiences, and many other genes all contribute to psychiatric disease.
Even so, this study provides some of the strongest evidence yet that several major mental disorders share common biological roots.
Rather than viewing schizophrenia, depression, bipolar disorder, ADHD, autism, and insomnia as completely separate illnesses, scientists are beginning to understand that they may arise from overlapping molecular mechanisms.
If future studies confirm these findings, this research could help move psychiatry toward a future where doctors identify biological risk earlier, diagnose mental illness more precisely, and develop treatments that address the disease process itself instead of simply reducing symptoms.
